They found that GLP-1 users had a 37% higher risk of alopecia than those taking SGLT-2 inhibitors, and a 68% higher risk compared with those using DPP-4 inhibitors
biologics (dupilumab, omalizumab, mepolizumab) now indicated for pediatric severe asthma 6 years
Your experience will depend on your dose, your habits, and how your body responds
The implications for longevity and healthspan are substantial, as preventing type 2 diabetes eliminates a cascade of downstream complications that would otherwise accumulate over decades
That said, here are a few steps to help you locate them: 1
However, health history, current medications, and individual goals all factor into whether this treatment is appropriate for a given patient